Skip to main content
Navamedic logo

Navamedic — Investor Relations & Filings

Ticker · NAVA ISIN · NO0010205966 LEI · 529900LKVQOR2SRUJU71 OL Wholesale and retail trade
Open in API
Filings indexed 825 across all filing types
Latest filing 2020-11-03 Report Publication Anno…
Country NO Norway
Listing OL NAVA

About Navamedic

https://navamedic.com/

Navamedic is a pharmaceutical company that develops, produces, and commercializes a diverse portfolio of medicines and related health products. The company's offerings include specialty pharmaceuticals, branded generics, and consumer health items. Its product portfolio addresses various medical needs, with treatments for conditions such as obesity, Parkinson's disorder, and inborn errors of metabolism, in addition to antibiotics. Serving as a reliable supplier and distribution partner, Navamedic provides high-quality products to hospitals and pharmacies, with a strong presence in the Nordic region and the Netherlands. The company focuses on improving patient outcomes through innovations, including advancements in personalized treatment for Parkinson's care.

Recent filings

Filing Released Lang Actions
Navamedic ASA: Invitation to 2020 third quarter presentation
Report Publication Announcement Classification · 96% confidence The document is titled 'Navamedic ASA: Invitation to 2020 third quarter presentation' and explicitly invites participants to a presentation of the Q3 figures via webcast. It provides the date, time, and location (webcast link). This is not the full financial report (IR or 10-K) nor the transcript of the call (CT). It is an announcement about an upcoming presentation of results, which aligns best with an Investor Presentation (IP) announcement or, more generally, a Report Publication Announcement (RPA) if the presentation itself is the primary focus being announced. Given the short length (663 chars) and the focus on inviting people to an event where results will be discussed, it strongly suggests an announcement related to an investor event. Since 'Investor Presentation' (IP) is an option, and this is an invitation to a presentation of quarterly figures, IP is the most specific fit, although RPA is also plausible if this were just a notice of the release of the presentation materials. I will classify it as IP as it is an invitation to the presentation event itself.
2020-11-03 English
Navamedic ASA - Registration of share capital increase
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces the 'Registration of share capital increase' following the exercise of employee share options. It details the resulting new share capital amount (NOK 11,315,994.90) and the total number of shares (15,291,885). This directly relates to changes in the company's capital structure through the issuance of new shares, which aligns perfectly with the definition for 'Share Issue/Capital Change' (SHA). The document length is short (1832 chars), but its content is a definitive announcement of a capital change, not just an announcement of a report, making SHA the most precise fit over RPA or RNS.
2020-10-07 English
Navamedic ASA: Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document text explicitly states 'Mandatory notification of trade' and details a transaction by the Chief Executive Officer (Kathrine Gamborg Andreassen) involving the exercise of share options and subsequent subscription for new shares, followed by a transfer to a related party. This type of insider transaction reporting, especially concerning personal share dealings by directors/executives, directly corresponds to the definition of 'Director's Dealing' (DIRS). The document length is very short (876 chars), but the content is a direct notification of a trade, not an announcement about the publication of a report, making DIRS the most specific fit over the general RNS fallback.
2020-09-30 English
NAVAMEDIC ASA: Resolution to increase the share capital in connection with exercise of employee options
Share Issue/Capital Change Classification · 98% confidence The document explicitly states a 'Resolution to increase the share capital in connection with exercise of employee options'. It details the issuance of 125,000 new shares to facilitate the exercise of share options by the CEO. This action directly relates to changes in the company's share structure and capital base resulting from employee compensation plans. This aligns precisely with the definition for 'Share Issue/Capital Change' (Code: SHA). It is not a general financing update (CAP), nor is it a transaction in own shares (POS), as it is an issuance related to option exercise, which is a specific form of capital change.
2020-09-30 English
Navamedic ASA: Q2 and first half 2020 financial results
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for Navamedic ASA covering the second quarter and the first half of 2020. It includes detailed financial statements (income statement, cash flow, balance sheet), management commentary, operational reviews, and notes to the financial statements. It is clearly an interim financial report rather than an annual report or a simple announcement, as it provides substantive financial data for the specified period. H1 2020
2020-08-20 English
Navamedic ASA: Q2 and first half 2020 financial results
Investor Presentation Classification · 95% confidence The document is a presentation titled '1H/Q2 2020 First half and second quarter results 2020 Navamedic ASA'. It contains financial highlights, strategic growth updates, and detailed consolidated profit and loss figures, balance sheets, and cash flow statements for the specified period. As it is a presentation deck used to communicate financial results and strategy to investors, it is classified as an Investor Presentation. H1 2020
2020-08-20 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.